Related Experiment Video
Updated: Mar 28, 2026

Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models
Published on: March 8, 2024
Steroidal Ammonium Compounds as New Neuromuscular Blocking Agents
Zhigang Rao1, Hao Hu1, Jiazhi Tang1
1State Key Laboratory of Virology, Ministry of Education Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Wuhan University School of Pharmaceutical Sciences, Wuhan, 430071, China.
New steroidal neuromuscular blocking agents show significantly enhanced potency for surgical anesthesia. These compounds offer improved muscle relaxation compared to existing drugs, addressing clinical needs.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Organic Synthesis
Background:
- Neuromuscular blocking agents are crucial in surgery for skeletal muscle relaxation.
- Existing agents have limitations, necessitating the development of improved alternatives.
Purpose of the Study:
- To synthesize and evaluate novel quaternary ammonium steroidal neuromuscular blocking agents.
- To identify compounds with superior potency and explore structure-activity relationships.
Main Methods:
- Synthesis of a series of quaternary ammonium steroidal compounds.
- Evaluation of bioactivity using isolated mouse phrenic nerve-hemidiaphragm preparations.
- Development of a facile purification method using pretreated silica gel chromatography.
Main Results:
- Compounds 3g and 4g demonstrated potent neuromuscular blocking activity (0.36–0.37 μm), significantly exceeding rocuronium (2.50 μm).
- Several bis-quaternized compounds exhibited potencies comparable to rocuronium.
- A benzyl group was identified as a key structural feature for enhanced activity.
Conclusions:
- Novel steroidal neuromuscular blocking agents possess significantly higher potency than rocuronium.
- The developed purification method effectively separates mono- and bis-quaternary compounds.
- These findings offer promising candidates for improved anesthetic adjuncts in surgical procedures.
More Related Videos
07:09Subcutaneous Administration of Muscarinic Antagonists and Triple-Immunostaining of the Levator Auris Longus Muscle in Mice
Published on: September 8, 2011
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Related Concept Videos
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Neuromuscular Junction And Blockade
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...